The Food and Drug Administration’s decision on reduction of events in high-risk patients was based primarily on the REDUCE-IT trial results.
When Melissa Gonzalez excitedly tweeted that she had been accepted to medical school earlier this year, she had no idea the tweet would draw...
News from the FDA/CDC
Unusual early spike related to increased influenza B activity, CDC says.
The move sets up criteria and requirements for future devices of the same type.
ORLANDO – ASH has released the first of five new sets of sickle cell disease guidelines, with the first focusing on screening and management of...
SAN DIEGO – Emerging evidence agrees: Lots of exercise, a good diet, and social interaction are good for both body and mind.
Over 1 million plans were selected on the insurance exchanges during Dec. 1-7, but history suggests this week will be much busier.
SAN DIEGO – The adverse event profile of the second-generation antipsychotic appears more benign than that typically seen with antipsychotics in...
From the Journals
Researchers examined factors associated with the length of time from first conventional synthetic disease-modifying antirheumatic drug to receipt...
SAN DIEGO – Recommendations support a new ED protocol, and addiction psychiatrists can play an important role.
BUSAN, SOUTH KOREA – Two experts came to different conclusions on this question during a heated, but jovial, debate last week at the International...